- Report
- February 2026
- 250 Pages
Global
From €3976EUR$4,490USD£3,407GBP
- Report
- February 2026
- 250 Pages
Global
From €3976EUR$4,490USD£3,407GBP
- Report
- February 2026
- 250 Pages
Global
From €3976EUR$4,490USD£3,407GBP
- Report
- May 2026
- 180 Pages
Global
From €3985EUR$4,500USD£3,414GBP
- Report
- November 2025
- 150 Pages
Global
From €3321EUR$3,750USD£2,845GBP
- Report
- July 2026
- 120 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- July 2026
- 112 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- July 2026
- 115 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- July 2026
- 114 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- October 2025
- 160 Pages
Global
From €2798EUR$3,160USD£2,398GBP
€3498EUR$3,950USD£2,997GBP
- Report
- July 2026
- 160 Pages
Global
From €3675EUR$4,150USD£3,149GBP
- Report
- July 2026
- 160 Pages
Global
From €3675EUR$4,150USD£3,149GBP
- Report
- April 2026
- 160 Pages
Global
From €2940EUR$3,320USD£2,519GBP
€3675EUR$4,150USD£3,149GBP
- Report
- October 2025
- 160 Pages
Global
From €2798EUR$3,160USD£2,398GBP
€3498EUR$3,950USD£2,997GBP
- Report
- October 2025
- 160 Pages
Global
From €2798EUR$3,160USD£2,398GBP
€3498EUR$3,950USD£2,997GBP
- Report
- November 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- October 2025
- 150 Pages
Global
From €4295EUR$4,850USD£3,680GBP
- Report
- May 2026
- 400 Pages
Global
From €3426EUR$3,869USD£2,936GBP
- Report
- October 2025
- 81 Pages
Global
From €3985EUR$4,500USD£3,414GBP
- Report
- February 2026
- 100 Pages
Middle East, Africa
From €4250EUR$4,799USD£3,641GBP

The Wearable Injector market is a subset of the Infusions and Injectables market, which includes a variety of medical devices used to deliver drugs, fluids, and other substances directly into a patient's body. Wearable Injectors are a type of infusion device that are designed to be worn on the body, allowing for continuous or periodic drug delivery. These devices are typically used to deliver medications such as insulin, hormones, and antibiotics, and can be used to treat a variety of conditions. Wearable Injectors offer a number of advantages over traditional infusion methods, including improved patient compliance, increased accuracy of drug delivery, and improved safety.
Some of the major players in the Wearable Injector market include Insulet Corporation, Valeritas, Inc., Becton Dickinson and Company, Tandem Diabetes Care, Inc., and Ypsomed AG. Show Less Read more